Everything on Healthcare Tech Investment

Dr. Lib's valuation dropped from €8.5 billion to €3.6 billion as pandemic-driven state mandates waned, though BioNTech investors see long-term IPO potential despite monopoly concerns.

Impact: Healthcare platforms dependent on state mandates face valuation corrections. Investors must assess regulatory risks regarding tiered pricing and patient prioritization.

— from OpenAI Media Acquisition, Anthropic Leak, and Prediction Market Regulation Trends · Doppelgänger Tech Talk· Apr 04, 2026